Aurora Cannabis Inc. (ACB)
| Market Cap | 187.57M -25.6% |
| Revenue (ttm) | 221.16M +12.3% |
| Net Income | -84.59M |
| EPS | -1.46 |
| Shares Out | 64.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,369,480 |
| Open | 3.330 |
| Previous Close | 2.890 |
| Day's Range | 3.260 - 3.530 |
| 52-Week Range | 2.560 - 6.665 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 6.27 (+79.91%) |
| Earnings Date | Aug 5, 2026 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
Analyst Summary
According to 6 analysts, the average rating for ACB stock is "Buy." The 12-month stock price target is $6.27, which is an increase of 79.91% from the latest price.
News
Aurora Cannabis to form special committee to consider Curaleaf proposal
Aurora Cannabis (ACB) responded today to a press release issued by Curaleaf Holdings (CURLF) regarding its stated intention to launch an unsolicited take-over bid for all of the issued and…
AURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC.
EDMONTON, AB, Aug. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, responded today to a p...
Tilray Brands stock rises as Curaleaf plots hostile takeover for Aurora
Tilray Brands stock rose by nearly 4% as investors rotated to companies in the cannabis industry after a report said that Curaleaf was planning a hostile bid for Aurora Cannabis. TLRY rose to an intra...
Aurora Cannabis (ACB) Stock Soars on a Proposed Takeover Bid from Curaleaf (CURLF)
Aurora Cannabis stock rallied on Tuesday after the company was listed as a potential takeover target by Curaleaf.
Aurora Cannabis trading halted, news pending
11:57 EDT Aurora Cannabis (ACB) trading halted, news pending
Curaleaf Plans Hostile Bid for Rival Aurora Cannabis
Curaleaf plans to launch a $272 million unsolicited takeover bid to acquire Canadian cannabis company Aurora after its board repeatedly refused to negotiate an acquisition deal.
Curaleaf intends to make $4.00 take-over bid for Aurora Cannabis
08:27 EDT Curaleaf (CURLF) intends to make $4.00 take-over bid for Aurora Cannabis (ACB)
Curaleaf to launch cash and stock take-over bid for Aurora Cannabis
08:28 EDT Curaleaf (CURLF) to launch cash and stock take-over bid for Aurora Cannabis (ACB)
Curaleaf intends to make $4.00 per share take-over bid for Aurora Cannabis
Curaleaf Holdings (CURLF) announces its intention to make an offer to purchase all of the issued and outstanding common shares of Aurora Cannabis (ACB) for consideration consisting of subordinate voti...
Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader
Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become owner...
Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General Meeting
EDMONTON, AB, Aug. 10, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announc...
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Aurora Cannabis NASDAQ: ACB said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company's nominees, reappoint...
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Profit from the Green Wave: Top Cannabis Stocks to WatchAurora Cannabis (NASDAQ:ACB) said shareholders approved all items presented at its annual general meeting, including setting the board size at f...
Aurora Cannabis Transcript: AGM 2026
The AGM reviewed strong fiscal 2026 results, with double-digit revenue growth, improved margins, and a robust cash position. All management proposals passed, including director elections and auditor appointment. Strategic focus remains on global medical cannabis leadership and international expansion.
Aurora Cannabis Q1 Earnings Call Highlights
Aurora Cannabis NASDAQ: ACB reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following r...
Aurora Cannabis Q1 Earnings Call Highlights
Profit from the Green Wave: Top Cannabis Stocks to WatchAurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales...
Aurora Cannabis Earnings Call Transcript: Q1 2027
International medical cannabis revenue grew 17% year-over-year, now representing 64% of total net revenue, while consolidated adjusted gross margin reached 58%. Despite Canadian reimbursement headwinds, strong international performance and the Safari acquisition support a positive outlook for sequential growth.
Aurora Cannabis Registration statement: Q1 2027
Aurora Cannabis filed a registration statement on August 5, 2026, providing details about a securities offering with the SEC.
Aurora Cannabis Registration statement: Q1 2027
Aurora Cannabis filed a registration statement on August 5, 2026, providing details about a securities offering with the SEC.
Aurora Cannabis Earnings release: Q1 2027
Aurora Cannabis released its Q1 2027 earnings on August 5, 2026, summarizing the period's financial results.
Aurora Cannabis Slides: Q1 2027
Aurora Cannabis has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 5, 2026.
Aurora Cannabis Earnings release: Q1 2027
Aurora Cannabis released its Q1 2027 earnings on August 5, 2026, summarizing the period's financial results.
Aurora Cannabis reports Q1 revenue C$67.6M vs. C$74.1M last year
The 9% decrease was mainly due to lower quarterly net revenue in Canadian medical cannabis and the wind down in consumer cannabis, offset by higher net revenue in international medical…
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
NASDAQ | TSX: ACB Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue Safari Flower Company Receives Three-Year EU-GMP Certification, Stre...